Larimar Therapeutics
LRMR
LRMR
59 hedge funds and large institutions have $126M invested in Larimar Therapeutics in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
48% more funds holding
Funds holding: 40 → 59 (+19)
17.67% more ownership
Funds ownership: 81.27% → 98.94% (+18%)
96% less call options, than puts
Call options by funds: $2K | Put options by funds: $49K
Holders
59
Holding in Top 10
2
Calls
$2K
Puts
$49K
Top Buyers
| 1 | +$35.6M | |
| 2 | +$9.15M | |
| 3 | +$6.21M | |
| 4 |
CA
CHI Advisors
New York
|
+$6.08M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.63M |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$292K | |
| 3 | -$100K | |
| 4 |
FFA
Fi3 Financial Advisors
Indianapolis,
Indiana
|
-$71.3K |
| 5 |
BlackRock
New York
|
-$17.1K |